The global hysteroscopic endometrial resection procedures market size was worth USD 219.4 million in 2021 and is estimated to grow to USD 297.3 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.2 percent during the forecast period.
The global hysteroscopic endometrial resection procedures market size was worth USD 219.4 million in 2021 and is estimated to grow to USD 297.3 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.2 percent during the forecast period. The report analyzes the hysteroscopic endometrial resection procedures market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the hysteroscopic endometrial resection procedures market.
Hysteroscopic endometrial resection techniques remove or destroy the uterine lining of the womb (uterus). This surgery is also known as transcervical endometrium resection (TCRE). Women with severe menstrual bleeding who no longer want children benefit significantly from the hysteroscopic endometrium resection procedure.
A hysteroscopic endometrial resection is a treatment option for menstrual blood loss after a hysteroscopic surgical procedure. Day surgery for hysteroscopic endometrial resection is associated with a significantly shorter hospital stay. In addition, the patient's overall recuperation time after surgery is considerably faster than with hysteroscopic surgery.
The increasing prevalence of menstrual bleeding and complications during women's periods will be the primary drivers of the market for hysteroscopic endometrial resection treatments. Growing NGO awareness of hysteroscopic endometrial excision as a safe method to stop excessive bleeding is also propelling the growth of this market.
The risk of uterine perforation during cervix stretching or hysteroscope insertion will limit the market's growth. Besides, a significant risk of acute pain in women following treatments may be a barrier to the market's growth.
The novel coronavirus pandemic has affected menstrual cycles globally, increasing the demand for endometrial resection devices. Following COVID-19 vaccination, many women worldwide reported abnormalities in their menstrual periods, with menorrhagia and intense or frequent bleeding before periods being common symptoms. These potential menstrual cycle irregularities will likely create opportunities for the hysteroscopic endometrial resection procedures industry to grow during the forecast period.
The rising prevalence of heavy menstrual bleeding and complications during women's periods are the primary drivers of the global hysteroscopic endometrial resection procedures market. Growing awareness programs by non-governmental organizations (NGOs) regarding hysteroscopic endometrial resection processes as a safe way to stop heavy menstrual bleeding are also driving the growth of this market.
According to the Endocrine Society (PCOS), polycystic ovary syndrome affects approximately 5%-20% of all women of fertility age. It is also the leading cause of infertility, expected to contribute to the global industry forecast.
Moreover, the increased emphasis on raising awareness of gynecological cancer and the rising incidence of endometriosis in women, especially after the age of 50, will have a positive impact on the hysteroscopic endometrial resection procedures market demand globally.
Furthermore, technological developments and the growing preference for minimally invasive procedures over conventional ones are other key drivers of the market's expansion.
Rising complications and risks associated with resection procedures globally hinder the market growth
The risk of perforation inside the uterine wall during cervix stretching or implantation of a hysteroscope limits the market's growth. Female patients are more likely to experience severe post-procedure pain, limiting the market's growth.
Complications and risks associated with hysteroscopic endometrial resection procedures, such as uterine perforation, difficulty breathing, and high fever, may hamper market dynamics.
Additionally, other treatment alternatives, including medication therapy (non-hormonal and hormonal), hysterectomy, and other medical procedures, restrain the expansion of the global market during the projected period.
The global hysteroscopic endometrial resection procedures market has been segmented into instrument type, end-user, and region.
By instrument type, the market is divided into hysteroscopes, assembled operative hysteroscopy, semi-rigid hysteroscopic scissors, operative hysteroscopes, continuous-flow operative hysteroscopes, and accessories. Among these, the hysteroscopes market is projected to expand faster during the forecast period owing to an increasing female geriatric population, an increased prevalence rate of postpartum hemorrhages, technological advancements, and increased awareness about women's health.
Based on end-users, the market is classified into hospitals, ambulatory surgical centers, and others. In 2021, the hospital category dominated the global market.
This is mainly due to a substantially higher inflow of patient populations for gynecological procedures compared to alternative settings, as healthcare facilities can handle emergencies that may arise after and during surgical procedures. Hospitals also provide a wide range of therapeutic options, fueling the market over the forecast period.
Recent Developments
Report Scope:
Due to the increased awareness concerning women's health and a rise in minimally invasive surgical procedures, North America dominates the global hysteroscopic endometrial resection procedures market. This can be attributed to favorable government regulations and reimbursement policies, the availability of key market players, increasing product approval and commercialization, and widespread awareness of the accessibility of diagnostic tests and treatments. For instance, the U.S. FDA approved UVision360's Luminelle DTx Hysteroscopy Process for both cystoscopy and hysteroscopy in 2019. The system enables doctors to perform hysteroscopic procedures in the office, including biopsy, and help detect tissue growth. Thus, the availability of healthcare technologies, the strength of the distribution channels, and the competition between well-known players regarding product innovation foster market growth in this region.
Hysteroscopic Endometrial Resection Procedures Market: Competitive Landscape
Some of the main competitors dominating the global hysteroscopic endometrial resection procedures market include - WISAP Medical Technology, Richard Wolf GmbH, Vimex Sp. z o.o., KARL STORZ GmbH & Co. KG, Stryker, Olympus Corporation, Teleflex Inc, Ethicon LLC, Centrel, Maxer Endoscopy, OPTOMIC, Medgyn Products Inc, and Henke-Sass Wolf.
FrequentlyAsked Questions
The main reasons anticipated to propel the hysteroscopic endometrial resection procedures market during the forecast period are the rising prevalence of uterine diseases, growing adoption of minimally invasive surgeries, and technological advancements in hysteroscopic devices.
According to the report, the global hysteroscopic endometrial resection procedures market was worth USD 219.4 million in 2021 and is estimated to grow to USD 297.3 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.2 percent during the forecast period.
North America will continue leading the hysteroscopic endometrial resection procedures market throughout the projected period. This can be attributed to favorable government regulations and reimbursement policies, the existence of key market players, increasing product approval and commercialization, and widespread awareness of the availability of diagnosis and treatment tests and treatments.
Some of the main competitors dominating the global hysteroscopic endometrial resection procedures market include - WISAP Medical Technology, Richard Wolf GmbH, Vimex Sp. z o.o., KARL STORZ GmbH & Co. KG, Stryker, Olympus Corporation, Teleflex Inc, Ethicon LLC, Centrel, Maxer Endoscopy, OPTOMIC, Medgyn Products Inc, and Henke-Sass Wolf.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed